Icon Clinical Research Inc is a Research and Development Laboratories business in North Wales, PA.
| Business Name: | Icon Clinical Research Inc |
| Categorized In: | Research and Development Laboratories |
| Address: | 2100 Pennbrook Parkway, North Wales, PA 19454 |
| Phone Number: | (215) 616-3000 |
| Contact Person: | Peter Gray, Chief Executive Officer |
| Website Address: | iconplc.com |
| NAICS Code: | 5417115 |
| SIC Code: | 8731 |
| Business Type: | B2B (Business to Business) |
| Founding Year: | 1992 |
| Employee #: | 1 to 4 |
| Location Type: | Headquarters |
| Annual Revenue ($): | Unknown |
| Share This Business: | |
| Similar Businesses: |
Icon Central Laboratories - North Wales, PA 19454 Saber Technologies LLC - North Wales, PA 19454 High Standard Products - North Wales, PA 19454 Cell & Molecular - North Wales, PA 19454 Allan S Xu - North Wales, PA 19454 Seneb Biosciences Inc - North Wales, PA 19454 G K Information Technology Inc - North Wales, PA 19454 |
Icon Clinical Research Inc, a stable growing company under Research and Development Laboratories, is being run by Peter Gray, Chief Executive Officer. Since , their sales have been favorable and consistent at Unknown. Company location coordinates are: 40.21991,-75.28998.
It can be reached by dialing (215) 616-3000, and you could get in touch with their sales team in 2100 Pennbrook Parkway, North Wales, Pennsylvania PA 19454. Visit their website at: iconplc.com to know more about the company’s history, products and services, as well as frequently asked questions and privacy policies.
Special deals are also offered from time to time. Their professional and honest business transactions fortifies both consumers and businesses in their B2B segments.
Their modest but solid headquarters houses 1 to 4 staff members. All are benefiting from the company’s generous programs and sound training solutions.
You can learn more by checking their classification codes: SIC – 8731 and NAIC – 5417115. Call the hotline stated above for faster transaction and queries. Icon Clinical Research Inc would like to hear from you.